We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$133B
1-Year Est. Return
43.5%
This Fund
S&P 500
This Quarter
Est. Return
+26.39%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$133B
AUM Growth
+$15.7B
(+13%)
Cap. Flow
-$1.75B
Cap. Flow
% of AUM
-1.32%
Top 10 Holdings %
Top 10 Hldgs %
30.35%
Holding
4,370
New
224
Increased
1,883
Reduced
1,827
Closed
182
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$117M |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$117M |
| 3 |
SPCX
SpaceX
SPCX
|
+$100M |
| 4 |
P
Everpure Inc
P
|
+$67.3M |
| 5 |
Roku
ROKU
|
+$53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$212M |
| 2 |
Microsoft
MSFT
|
+$156M |
| 3 |
Amazon
AMZN
|
+$142M |
| 4 |
Honeywell
HON
|
+$119M |
| 5 |
NVIDIA
NVDA
|
+$94.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.1% |
| 2 | Financials | 11.93% |
| 3 | Industrials | 10.35% |
| 4 | Consumer Discretionary | 9.64% |
| 5 | Healthcare | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
OceanFirst Financial
OCFC
$1.65B
| $2.12M | ﹤0.01% |
108,314
+43,247
| +66% | +$806K |
|
1877
Quanex
NX
$905M
| $2.11M | ﹤0.01% |
113,341
-18,945
| -14% | -$350K |
|
|
SAFE
1878
Safehold
SAFE
$868M
| $2.11M | ﹤0.01% |
134,175
-15,694
| -10% | -$238K |
|
|
ATAI
1879
DELISTED
AtaiBeckley Inc
ATAI
| $2.11M | ﹤0.01% |
+399,436
| New | +$1.68M |
|
|
VOYG
1880
Voyager Technologies
VOYG
$1.91B
| $2.09M | ﹤0.01% |
64,943
+13,626
| +27% | +$472K |
|
1881
Matthews International
MATW
$591M
| $2.09M | ﹤0.01% |
77,747
-14,496
| -16% | -$390K |
|
|
CCC
1882
CCC Intelligent Solutions
CCC
$4.06B
| $2.09M | ﹤0.01% |
404,953
-60,538
| -13% | -$299K |
|
1883
Hamilton Insurance Group
HG
$3.28B
| $2.08M | ﹤0.01% |
61,298
+3,493
| +6% | +$110K |
|
|
PVLA
1884
Palvella Therapeutics
PVLA
$1.99B
| $2.07M | ﹤0.01% |
13,528
+4,399
| +48% | +$534K |
|
1885
Absci
ABSI
$1.67B
| $2.07M | ﹤0.01% |
178,359
+17,751
| +11% | +$100K |
|
|
NAB
1886
DELISTED
NATL AUSTRALIA BK LTD ADS5
NAB
| $2.07M | ﹤0.01% |
158,207
+9,495
| +6% | +$124K |
|
1887
MarineMax
HZO
$1.16B
| $2.06M | ﹤0.01% |
56,388
-7,720
| -12% | -$248K |
|
1888
Bank First Corp
BFC
$1.69B
| $2.06M | ﹤0.01% |
13,887
+1,689
| +14% | +$241K |
|
1889
Teladoc Health
TDOC
$1.11B
| $2.06M | ﹤0.01% |
242,785
+13,622
| +6% | +$90.6K |
|
1890
NovoCure
NVCR
$1.84B
| $2.06M | ﹤0.01% |
135,790
+13,842
| +11% | +$209K |
|
|
MBX
1891
MBX Biosciences
MBX
$2.58B
| $2.05M | ﹤0.01% |
37,196
+3,325
| +10% | +$116K |
|
1892
Ezcorp Inc
EZPW
$1.91B
| $2.05M | ﹤0.01% |
59,185
-22,151
| -27% | -$699K |
|
1893
Taysha Gene Therapies
TSHA
$1.52B
| $2.04M | ﹤0.01% |
299,975
+41,445
| +16% | +$245K |
|
1894
Live Oak Bancshares
LOB
$1.73B
| $2.04M | ﹤0.01% |
49,849
+2,543
| +5% | +$95.1K |
|
1895
Amylyx Pharmaceuticals
AMLX
$3.76B
| $2.03M | ﹤0.01% |
112,920
+4,453
| +4% | +$68.9K |
|
1896
UroGen Pharma
URGN
$2.02B
| $2.02M | ﹤0.01% |
54,922
+5,515
| +11% | +$149K |
|
1897
AstraZeneca
AZN
$258B
| $2.02M | ﹤0.01% |
10,654
-96
| -0.9% | -$18.1K |
|
1898
BellRing Brands
BRBR
$920M
| $2.02M | ﹤0.01% |
156,013
-153,142
| -50% | -$1.85M |
|
1899
Turning Point Brands
TPB
$1.24B
| $2.02M | ﹤0.01% |
23,772
+1,704
| +8% | +$141K |
|
1900
BP
BP
$114B
| $2.01M | ﹤0.01% |
54,509
+3,112
| +6% | +$137K |
|
Similar funds
RhumbLine Advisers's Q2 2026 Portfolio in Review
As of Q2 2026, RhumbLine Advisers held 4,370 positions worth $133B, up 13% from $117B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
RhumbLine Advisers's Q2 2026 filing shows 224 new, 1,883 increased, 1,827 reduced and 182 closed positions. Its largest new stake was Honeywell Aerospace: 529,091 shares worth $117M. The largest sale was Apple, an estimated $212M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Financials and Industrials.
- RhumbLine Advisers's largest Q2 2026 buy was Honeywell Aerospace: 529,091 shares worth $117M.
- RhumbLine Advisers added most to Marvell Technology in Q2 2026, an estimated $117M increase.
- RhumbLine Advisers's biggest Q2 2026 reduction was Apple, cutting an estimated $212M.
- RhumbLine Advisers fully exited Coterra Energy in Q2 2026, selling an estimated $53.5M.
- RhumbLine Advisers's ten largest holdings make up 30% of its $133B portfolio in Q2 2026.
- RhumbLine Advisers opened 224 new positions and closed 182 in Q2 2026.
- RhumbLine Advisers's portfolio value rose 13% quarter-over-quarter to $133B.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.